Model for Heart Failure ExAcerbation Reduction Trial

CompletedOBSERVATIONAL
Enrollment

230

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Acute on Chronic Heart Failure
Interventions
OTHER

Parameter Based Clinical Disposition

"Parameter Based Clinical Disposition'~Physicians will initiate / titrate medications and obtain consults as usual but are highly encourage to keep patients in the hospital until at least 2 of the following 3 criteria are met:~* NT-ProBNP reduction of \> 23% from peak value during admission~* Fluid Reduction of \> 1.3L (orders for I/O q8h required)~* Serum Sodium of \> 135 mmol/L the day of planned discharge"

Trial Locations (1)

33331

Cleveland Clinic Florida, Weston

All Listed Sponsors
lead

Cleveland Clinic Florida

OTHER

NCT01726985 - Model for Heart Failure ExAcerbation Reduction Trial | Biotech Hunter | Biotech Hunter